Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 6 | Brown ShellyEVP, Chief Strategy Officer | Open-market sale · 10b5-1 plan | SELL | $38K 900 sh |
| Apr 8, 2026 traded Apr 7, 2026 |
| 6 | Gibson ChristopherDirector | Open-market sale · 10b5-1 plan | SELL | $124K 40.0K sh | Apr 8, 2026 traded Apr 7, 2026 |
| 5 | Porter James RichardDirector, President and CEO | Option exercise · 10b5-1 plan | M | $260K 13.7K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 5 | Ragosa MarkCHIEF FINANCIAL OFFICER | Option exercise | M | — 2,694 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 5 | Lin MarkEVP and CFO | Grant or award | A | — 450 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 5 | Tessari EbenCHIEF STRATEGY OFFICER | Tax withholding | F | $41K 846 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 5 | Tessari EbenCHIEF STRATEGY OFFICER | Option exercise | M | — 2,726 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 5 | Porter James RichardDirector, President and CEO | Option exercise · 10b5-1 plan | M | $454K 16.3K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 4 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | — 14.7K sh | Apr 8, 2026 traded Apr 8, 2026 |
| 4 | Prahm JeremyChief Investment Officer | Open-market sale · 10b5-1 plan | SELL | $93K 5,228 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 4 | Allison JonathanChief Administrative Officer | Open-market sale · 10b5-1 plan | SELL | $76K 1,706 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 3 | Choudary Kiran KumarChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $48K 900 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 3 | Moat RossCHIEF OPERATING OFFICER | Option exercise · 10b5-1 plan | M | — 2,477 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 3 | Porter James RichardDirector, President and CEO | Option exercise · 10b5-1 plan | M | — 13.7K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 3 | Porter James RichardDirector, President and CEO | Option exercise · 10b5-1 plan | M | — 16.3K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 2 | Cowan ElviaSVP, Finance & CAO | Option exercise · 10b5-1 plan | M | $78K 3,000 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 0 | Gibson ChristopherDirector | Derivative conversion · 10b5-1 plan | C | — 40.0K sh | Apr 8, 2026 traded Apr 7, 2026 |
| 0 | Desmond SeanDirector, CEO & President | Option exercise · 10b5-1 plan | M | $40K 8,065 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 52.4K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | Cannestra AnthonyDirector | Option exercise · 10b5-1 plan | M | $28K 50.0K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | Date Rajeev VDirector | Option exercise · 10b5-1 plan | M | $204 2,546 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | Venturo Brian MDirector, Chief Strategy Officer | Derivative conversion · 10b5-1 plan | C | — 900.0K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | $144K 11.9K sh | Apr 8, 2026 traded Apr 8, 2026 |
| 0 | Feuardent Moreira AndreasChief Innovation Officer | Option exercise · 10b5-1 plan | M | — 10.0K sh | Apr 8, 2026 traded Apr 7, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 6,250 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | Desmond SeanDirector, CEO & President | Option exercise · 10b5-1 plan | M | — 8,065 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | Doyle MittieChief Medical Officer | Option exercise · 10b5-1 plan | M | — 3,970 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 52.4K sh | Apr 8, 2026 traded Apr 8, 2026 |
| 0 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 52.4K sh | Apr 8, 2026 traded Apr 7, 2026 |
| 0 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | — 14.7K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | $107K 14.7K sh | Apr 8, 2026 traded Apr 8, 2026 |
| 0 | Tenev VladimirDirector, Chief Executive Officer | Derivative conversion · 10b5-1 plan | C | — 375.0K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | Venturo Brian MDirector, Chief Strategy Officer | Derivative conversion · 10b5-1 plan | C | — 900.0K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 16.7K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 27.1K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | Date Rajeev VDirector | Option exercise · 10b5-1 plan | M | — 2,546 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 100.0K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | Venturo Brian MDirector, Chief Strategy Officer | Derivative conversion · 10b5-1 plan | C | — 225.0K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 16.7K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | Cowan ElviaSVP, Finance & CAO | Option exercise · 10b5-1 plan | M | — 3,000 sh | Apr 8, 2026 traded Apr 7, 2026 |